Recently, miR-103 and miR-107 were reported to be upregulated in the livers of leptin-deficient (ob/ob) and diet-induced obese (DIO) mice and antisense therapy improved insulin sensitivity and glucose homeostasis in mouse models; thus microRNAs are attractive therapeutic targets in insulin resistance [47]. This evidence concerns the gene LEP and Insulin resistance.